Skip to main content
Year archive

Genexine, Inc. — 2021 filings

All 45 regulatory filings released by Genexine, Inc. (095700) in 2021, sourced directly from the official regulator.

45 Filings
2021 Period
2021 filings (45)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-16 Korean
[기재정정]주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2021-12-16 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-15 Korean
투자판단관련주요경영사항(재발성 교모세포종 환자에서 베바시주맙 (bevacizumab) 과 GX-I7 병용 투여의 유효성 및 안전성을 확인하기 위한 2상 임상시험계획 변경 승인)
Regulatory Filings
2021-11-10 Korean
[기재정정]신규시설투자등
Regulatory Filings
2021-10-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-14 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-14 Korean
대표이사변경
Board/Management Information
2021-09-01 Korean
투자판단관련주요경영사항(COVID-19 예방 DNA 백신 GX-19N 의 2/3상 임상시험 계획 변경 신청)
Legal Proceedings Report
2021-08-30 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-17 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-08-13 Korean
수시공시의무관련사항(공정공시)
Board/Management Information
2021-07-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-15 Korean
투자판단관련주요경영사항(COVID-19 예방 DNA 백신 GX-19N 의 2/3상 임상시험 계획 인도네시아 식약처 승인)
Legal Proceedings Report
2021-07-07 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-06-25 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-06-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-05-27 Korean
타법인주식및출자증권처분결정
M&A Activity
2021-05-20 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-17 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2021
2021-05-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-03-29 Korean
대표이사변경
Board/Management Information
2021-03-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-03-29 Korean
사업보고서 (2020.12)
Annual Report FY 2020
2021-03-19 Korean
전환가액의조정
Share Issue/Capital Change
2021-03-17 Korean
투자판단관련주요경영사항(COVID-19 예방 DNA 백신 GX-19N 의 2/3상 임상시험 계획 신청)
Legal Proceedings Report
2021-03-17 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-12 Korean
주주총회소집공고
AGM Information
2021-03-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-03-03 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-02-19 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-02-19 Korean
[기재정정]주주총회소집결의
AGM Information
2021-02-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-02-18 Korean
투자판단관련주요경영사항(GX-I7 (면역항암제) 기술이전 계약체결)
M&A Activity
2021-02-18 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-02-18 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2021-02-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-01-20 Korean